The highly specific and tunable exogenous control of human PRMT1 could be important in modulating epigenetic factors and post-translational modifications that result in changes in gene expression, particularly with the application to control histone methylation in disease states such as cancer. This evidence concerns the gene PRMT1 and cancer.